Aug 24, 2026 06:40AM
Jul 29, 2026 07:00AM
Jul 21, 2026 06:12AM
Jul 13, 2026 06:41AM
Jun 25, 2026 07:12AM
Jun 25, 2026 06:48AM
Jun 25, 2026 02:59AM Ionis licenses zilganersen to Recordati for ex-U.S. markets
Jun 25, 2026 02:59AM
Jun 1, 2026 06:57AM
May 27, 2026 06:44AM
Apr 29, 2026 04:10PM
Apr 29, 2026 07:00AM
Apr 28, 2026 02:06AM
Apr 28, 2026 02:06AM Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
Apr 21, 2026 07:03AM
Apr 21, 2026 07:00AM
Mar 25, 2026 03:42PM
Mar 25, 2026 12:24PM
Mar 25, 2026 11:44AM
Mar 25, 2026 10:13AM
Mar 23, 2026 07:00AM FDA grants priority review to Ionis' Alexander disease treatment
Mar 23, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 25, 2026 07:00AM
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy
Jul 30, 2025 07:00AM
Jul 21, 2025 07:00AM
Jul 21, 2025 07:00AM
Apr 30, 2025 07:00AM
Apr 7, 2025 06:34AM
Feb 20, 2025 07:03AM
Feb 20, 2025 07:00AM New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control
Feb 20, 2025 05:50AM
Feb 19, 2025 02:52PM
Feb 19, 2025 07:00AM
Dec 20, 2024 07:18AM
Nov 6, 2024 07:00AM
Nov 4, 2024 09:45AM
Nov 4, 2024 09:44AM Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
Sep 26, 2024 06:23AM
Aug 1, 2024 07:00AM
Jun 25, 2024 06:55AM
Jun 25, 2024 06:55AM
Mar 13, 2024 03:02PM
Oct 4, 2023 07:00AM
Sep 28, 2023 12:02PM Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit
Aug 9, 2023 07:00AM

15,713 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All